---
title: "Cypherpunk Technologies Inc. (CYPH.US)"
type: "Symbol"
locale: "en"
url: "https://longbridge.com/en/quote/CYPH.US.md"
symbol: "CYPH.US"
name: "Cypherpunk Technologies Inc."
industry: "Biotechnology"
datetime: "2026-06-13T22:01:45.120Z"
locales:
  - [en](https://longbridge.com/en/quote/CYPH.US.md)
  - [zh-CN](https://longbridge.com/zh-CN/quote/CYPH.US.md)
  - [zh-HK](https://longbridge.com/zh-HK/quote/CYPH.US.md)
---

# Cypherpunk Technologies Inc. (CYPH.US)

## Company Overview

Cypherpunk Technologies Inc., a privacy technology company, implements a digital asset strategy anchored by Zcash in the United States. The company is involved in identifying, developing, investing in, acquiring, and building privacy-enhancing technologies; and accumulating digital assets, such as ZCash. It also develops biomarker-targeted antibody therapies for patients with cancer and other diseases comprising DKN-01, a monoclonal antibody that inhibits Dickkopf-related protein 1, which has completed Phase 2 study for the treatment of colorectal cancer; and FL-501, a monoclonal antibody inhibiting the GDF-15 protein, which is in preclinical development to treat cancer cachexia, hyperemesis gravidarum and pregnancy-related nausea and vomiting, and other diseases associated with aging and frailty. The company was formerly known as Leap Therapeutics, Inc.

| Item | Detail |
|------|--------|
| Industry | Biotechnology |
| Exchange | US Market |
| Website | [www.cypherpunk.com](https://www.cypherpunk.com) |

## Key Drivers
> *AI-analyzed key factors driving this stock's performance*


## Longbridge Financial Score™: 
> *Longbridge Financial Score™ — Proprietary multi-factor rating model by Longbridge*
> Updated: 1970-01-01T00:00:00.000Z

**Overall:  (0.00)**

## Valuation Analysis

| Metric | Current | Industry Ranking | High | Median | Low |
|--------|---------|-----------------|------|--------|-----|
| PE (TTM) | -1.22 | 197 | 19.78 | 16.31 | 13.61 |
| PB | 0.82 | 84 | 24.38 | 13.14 | 0.58 |
| Dividend Yield | 0.00% | - | - | - | - |

## Institutional View

### Analyst Rating Distribution

> As of 2025-05-14T04:00:00.000Z

Total Analysts: **1**

| Rating | Count | Percentage |
|--------|-------|-----------| 
| Hold | 1 | 100% |

### Target Price Forecast

| Metric | Price |
|--------|-------|
| Current Price | 0.65 |
| Highest Target | undefined |
| Lowest Target | undefined |

## References

- [Company Overview — Profile, executives, shareholders, business breakdown](https://longbridge.com/en/quote/CYPH.US/overview.md)
- [Financial Reports — Income, balance sheet, cash flow, dividends](https://longbridge.com/en/quote/CYPH.US/norm.md)
- [Related News](https://longbridge.com/en/quote/CYPH.US/news.md)
- [Filings — Company announcements and regulatory filings](https://longbridge.com/en/quote/CYPH.US/filings.md)

---

> **Disclaimer: This article is for reference only and does not constitute any investment advice.**